tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX

Shield Therapeutics (STX) Ownership - Who Owns Shield Therapeutics?

7 Followers

Shield Therapeutics (STX) Ownership Overview

3.84%0.00%0.00%96.16%
0.00% Other Institutional Investors
96.16% Public Companies and
Individual Investors
The ownership structure of Shield Therapeutics (GB:STX) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 3.84% is owned by Insiders and 96.16% is owned by Public Companies and Individual Investors.
The ownership structure of Shield Therapeutics (GB:STX) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 3.84% is owned by Insiders and 96.16% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 27, 2023
Hans Peter Hasler
Chairman,director
Bought£122000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,198,951Insider1.30%206,529
9,901,713Insider1.27%200,510
5,500,000Insider0.70%111,375
1,893,039Insider0.24%38,334
1,748,700Insider0.22%35,411
271,886Insider0.03%5,506
186,666Insider0.02%3,780
161,667Insider0.02%3,274
89,053Insider0.01%1,803
83,701Insider0.01%1,695

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Shield Therapeutics PLC (GB:STX)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 3.84% is held by insiders, and 96.16% is held by retail investors.
    What percentage of Shield Therapeutics PLC (GB:STX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.00% of Shield Therapeutics PLC (GB:STX) stock is held by institutional investors.
      What percentage of Shield Therapeutics PLC (GB:STX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 96.16% of Shield Therapeutics PLC (GB:STX) stock is held by retail investors.
        Who owns the most shares of Shield Therapeutics PLC (GB:STX)?
        Carl Sterritt owns the most shares of Shield Therapeutics PLC (GB:STX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis